Evaluation of the Antifungal Activity of the Polyphenol Formulation Viroelixir Against Candida albicans
Open Access
- 21 April 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (4) , 420
Abstract
Candida albicans (C. albicans) is an opportunistic fungal pathogen capable of causing a wide range of infections, including mucosal and systemic candidiasis. In the oral cavity, fungi represent a minor component of the microbiome but can significantly contribute to morbidity, particularly under conditions of dysbiosis or immunosuppression. Treatment remains challenging due to increasing multidrug resistance. This study investigates the in vitro antifungal potential of Viroelixir, a standardized polyphenol blend derived from green tea and pomegranate and enriched in catechins (including epigallocatechin gallate, EGCG), ellagitannins (notably punicalagin), ellagic acid, and flavonoids, with particular focus on its potential anti-virulence mechanisms. Methods: The effect of Viroelixir on C. albicans growth was assessed using MTT assay, optical density measurements, colony formation, carbohydrate quantification, and pH variation analysis. Biofilm formation, morphological transition, ROS production, necrosis, virulence gene expression, adhesion, and host immune responses were also evaluated. Results: Viroelixir significantly inhibited C. albicans growth and reduced colony formation compared with untreated controls. The formulation also inhibited biofilm formation and markedly reduced pseudohyphal development, reaching up to 94% reduction under specific treatment conditions. Flow cytometry analysis showed an increase in dead fungal cells, reaching approximately 88% following exposure to Viroelixir at the highest tested concentration. In addition, Viroelixir reduced the transcript levels of several virulence-associated genes, including SAP1–SAP9 and EAP1. In epithelial cell co-culture models, pre-treatment of C. albicans with Viroelixir reduced fungal adhesion and attenuated epithelial inflammatory responses, including IL-6, IL-8, and hBD-2 production, and was associated with reduced activation of the TLR4-NF-κB signaling pathway. Conclusions: These findings suggest that the antifungal and anti-virulence effects observed may be associated with the polyphenolic compounds present in the Viroelixir formulation, highlighting its potential as a promising in vitro antifungal candidate against C. albicans.Keywords
This publication has 87 references indexed in Scilit:
- Licochalcone A Protects Vaginal Epithelial Cells Against Candida albicans Infection Via the TLR4/NF-κB Signaling PathwayJournal of Microbiology, 2024
- Candida species as potential risk factors for oral squamous cell carcinoma: Systematic review and meta-analysisCancer Epidemiology, 2023
- Assessing pH‐dependent activities of virulence factors secreted by Candida albicansMicrobiologyopen, 2023
- Naringin‐generated ROS promotes mitochondria‐mediated apoptosis in Candida albicansIUBMB Life, 2021
- TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signalingCellular and Molecular Life Sciences, 2020
- Effect of Dermaseptin S4 on C. albicans Growth and EAP1 and HWP1 Gene ExpressionProbiotics and Antimicrobial Proteins, 2020
- Modulation of Candida albicans Biofilm by Different Carbon SourcesMycopathologia, 2016
- Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouseCellular Immunology, 2015
- Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative TreatmentMycopathologia, 2014
- Effects of Antifungal Agents in Sap Activity of Candida albicans IsolatesMycopathologia, 2009